Potential Policy Changes that Could Upend Prescription Drug Pricing
On November 3, 2021, Congress introduced a working draft of the Build Back Better ...
Roadmap to Improved Coverage and Access for Specialty Products
As specialty pharmaceutical products are becoming increasingly complex due to more technology-driven drug development, ...
Improving Your Patient Support Programs for Expanded Affordability
Patient support programs (PSPs), patient assistant programs (PAPs), copay coupons, or whatever name you ...
Establishing a Successful Pharma-Payer Relationship in 2022
If a life sciences company wants to start their relationship with a payer off ...
Two Key Questions About Payer Strategies in 2022
PM360 asked experts in dealing with payers to tell us the optimal strategies for ...
Advancing Medical Affairs to be a Value-Based Strategic Partner
Over the past decade, the healthcare landscape has changed dramatically with an increased emphasis ...
Are Big Changes on the Way in Market Access?
While the Biden administration’s Build Back Better Act continues to be debated and revised ...
How Amazon Care’s Nationwide Expansion Will Impact Healthcare
When Amazon launched its healthcare service, Amazon Care, in September 2019, McKinsey reported only ...
Healthcare Watch April 2022
Doctor Docs: Physicians are Fed Up with COVID-19 Misinformation Around the world, 55% of ...
Industry Briefs April 2022
Collaboration Aims to Revolutionize Vaccine Development physIQ, a pioneer in digital medicine, and CellCarta, ...
Need Self-Care? Try Taking a Sound Bath
Perhaps one silver lining to the past years of upset and unrest is the ...
Ignored Caregivers Suffer from an Information Void
Over the course of the last several years, pharma companies have tailored their messaging ...
Three Key Insights About the Prescription Journey in 2022 and Beyond
As the U.S. enters a new phase and shifts from the crisis mode of ...
